Claim your FREE trial subscription!
Medical Markets:
Life Science Informatics: Strategies & Business Models (report)
Datacomm Research
Market Study May 2003
Life science informatics promises to harness the flood of data from the Human Genome Project and related research. But living organisms are complex, and designing drugs exclusively in silico is not ready for prime time. Based on months of research, this report sheds new light on the life science informatics industry: what's real, what's not, and how today's science-driven ventures can become tomorrow's profit makers.
More life science informatics vendors target drug R&D than the market can support, while few target diagnostic applications that could quickly scale up to the larger point-of-care market. That is one of the main conclusions of the new 143-page report Life Science Informatics: Strategies & Business Models, released today by Datacomm Research Company.
"Drug discovery is vital and glamorous, but the number of large pharmaceutical and biotech companies is relatively small," said Ira Brodsky, primary author of the report and President of Datacomm Research. "The opportunities for providing faster and more accurate diagnosis, treatment personalization, and effectiveness monitoring are wide open," he concluded.
Life Science Informatics: Strategies & Business Models is the latest in Datacomm Research’s CompetitiveEdge™ series. The report is based on more than two dozen in-depth interviews and includes sections on life science informatics applications and markets, information technology infrastructure (including storage area networks, server clusters, and grid computing), and business models. More than 70 vendors—from 3rd Millenium, Inc. to Visualize, Inc.—are profiled.
Datacomm Research Company is a leader in tracking, analyzing, and forecasting emerging high tech markets. Other Datacomm reports include Third Generation Wireless, Digital Cameras, and Voice of the Internet.
Executive Summary
The current market
Opportunities & illusions
Business models & strategies
Conclusions & recommendations
Mapping the Genome and Searching for Profits
Life Science Informatics
Applications
Research
Health care
Pharmaceuticals
Agriculture
Veterinary
Food processing
Forensics
Manufacturing
IT applications
Information technology (IT) infrastructure
Data access
Data storage
Computing architectures
The Market
Pharmaceutical and biotech firms
Government and university research labs
Healthcare providers
Information Technology Opportunities & Requirements
Regulatory Issues
Business models
Focus: Hardware
Computing hardware sales
Storage hardware sales
Networking hardware sales
Instrumentation hardware sales
Focus: Life Science Informatics Services
Application Service Provider (ASP)
Outsourced Drug Discovery Processes
Consulting
Focus: Software
Discipline-based tools
Task-based tools
Software: off-the-shelf
Software: customized for flat fee
Software licensing: free with charges for upgrades, support, and extras
Software licensing: modest upfront fee plus royalties
Software licenses: upfront fee plus annual maintenance and consulting
Focus: Systems & Other
Integration model
Eclectic model
Strategic collaboration/acquisition model
Drug discovery model
Healthcare applications model
Vendor Profiles
3rd MILLENIUM INC.
ACCELRYS
ACLARA
AFFYMETRIX
AGILENT TECHNOLOGIES
ALGONOMICS
ALKAMI BIOSYSTEMS
ANVIL
ARQULE
APPLIED BIOSYSTEMS GROUP
BIODISCOVERY
BIOINFORMATICS SOLUTIONS
BIOSENTIENTS
BIOTOOLS INC.
BLACKSTONE COMPUTING
CALLIDA GENOMICS
CB TECHNOLOGIES
CELERA GENOMICS
CEREP
COMPUGEN
CURAGEN
DECODE GENETICS
DECODON
DELTAGEN, INC.
DISCOVERY PARTNERS INTERNATIONAL
ENTELOS INC.
GENEDATA
GENEFORMATICS, INC.
GENEPROT
GENE LOGIC
GENODYSSEE
GENOME THERAPEUTICS CORP.
GENOMICS COLLABORATIVE
GENOMIC SOLUTIONS
GEOSPIZA
HEWLETT-PACKARD
IBM LIFE SCIENCES
IMAGING RESEARCH
INCYTE GENOMICS, INC.
INFORMAX
KSHEMA TECHNOLOGIES
LABSTREAM
LARGE SCALE BIOLOGY CORP.
LINUX NETWORX
LION BIOSCIENCE
MOLECULAR MINING
MOTOROLA LIFE SCIENCES
NANOGEN
NEXUS GENOMICS
PANVERA LLC
PARACEL
PARTEK
PERLEGEN SCIENCES
PHARSIGHT
PHASE FORWARD
PHT CORPORATION
PHYSIOME SCIENCES
PLATFORM COMPUTING
ROSETTA INPHARMICS
SILCON GENETICS
SPOTFIRE
STRAND GENOMICS PVT. LTD.
STRUCTURAL BIOINFORMATICS INC.
STRUCTURAL GENOMICS
THIRD WAVE TECHNOLOGIES
TIMELOGIC
TISSUEINFORMATICS
TRIPOS
TURBOWORX
UNITED DEVICES
VISUALIZE INC.
| Tables |
| Table 1 Factors Driving/Inhibiting Life Science Informatics Business |
| Table 2 Major life science informatics activities |
| Table 3 Major supercomputer manufacturers |
| Table 4 Twenty largest supercomputing sites |
| Table 5 Comparison of supercomputers, server clusters, and grid computing |
| Table 6 Major manufacturers of server clusters |
| Table 7 Comparison of high speed network interfaces |
| Table 8 The largest pharmaceutical and biotech firms |
| Table 9 Buyer profiles for four major life science informatics market segments |
| Table 10 Growth in GenBank database, 1982 - 2002 |
| Table 11 Advantages & disadvantages (for customers) of using application service providers (ASPs) |
| Table 12 Business model evolution for select life science informatics vendors |
| Figures |
| Figure 1 Major high performance computing architectures (supercomputer, server cluster, and grid) |
| Figure 2 Percentage of top 500 high performance computing sites dedicated to life sciences |
| Figure 3 Blade server architecture saves space and reduces power consumption |
| Figure 4 Growth in European Molecular Biology Laboratory (EMBL) database, 1982 - 2003 |
| Figure 5 New drug applications, 1995 – 2003 (first part of 2003) |
| Figure 6 Drug development & approval process |
| Figure 7 Breakdown of drug development costs, US$ millions |
For full details, please email jenniferc@cmsinfo.com
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved
For more information about us, visit CMSinfo.
